On September 17, 2024, United For Patent Reform joined a host of organizations representing the nation's leading technology and microchip manufacturers, generic and biosimilar manufacturers, Main Street retailers, grocers, hotels, restaurants, and well respected think tanks focused on intellectual property in sending a letter to the Senate Judiciary Committee, urging them to not proceed with a markup of the Promoting and Respecting Economically Vital American Innovation Leadership Act (the “PREVAIL Act”). The proposed legislation would damage U.S. industry, discourage commerce, and place further inflationary pressure on the prices that Americans pay for goods and services— principally for the benefit of shell companies, foreign patent owners, and litigation investment funds. Read the full letter:
top of page
Recent Posts
See AllOn September 17, 2024, United for Patent Reform joined the nation’s leading microchip and technology manufacturers, generic and...
United for Patent Reform sent a joint letter today to the Senate Judiciary Committee stressing how harmful the Patent Eligibility...
In a joint coalition letter, UFPR urged the Senate Judiciary Committee to not move forward with the PREVAIL Act, pointing to the many...
bottom of page